Biotech · Private company
Atlas Molecular Pharma
Track this companyFree. Adds Atlas Molecular Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ATL-001 (Ciclopirox oral solution)Phase 2 · Congenital Erythropoietic Porphyria (CEP)ClinicalTrials.gov · fetched Nov 12, 2026
- Ciclopirox Olamine OralPhase 1 · Adverse Effect of Drugs and Medicaments in Therapeutic UseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEPPHASE1_PHASE2 · RECRUITING · started Jan 29, 2026ClinicalTrials.gov NCT07024316 · fetched Nov 12, 2026
- Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy VolunteersPHASE1 · COMPLETED · started Mar 31, 2023ClinicalTrials.gov NCT05647343 · fetched Nov 12, 2026